- Citations, last 5 years
- 0
- Works, last 5 years
- 0
- h-index
- 1
- Scientists listed
- 0
- Grants since 2016
- 11
Grants received
2021 · research · R44
Administrative Supplement for the Evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer
Kristy Perez · CivaTech Oncology (United States) · funded by National Institutes of Health
2017–2021 · research · R44
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer
Kristy Perez · CivaTech Oncology (United States) · funded by National Institutes of Health
2017–2018 · research · R44
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer
Kristy Perez · CivaTech Oncology (United States) · funded by National Institutes of Health
2017–2020 · research · R44
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer
Kristy Perez · CivaTech Oncology (United States) · funded by National Institutes of Health
2017–2020 · research · R44
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Pancreatic Cancers
Kristy Perez · CivaTech Oncology (United States) · funded by National Institutes of Health
2017–2022 · research · R44
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer
Kristy Perez · CivaTech Oncology (United States) · funded by National Institutes of Health
2017–2019 · research · R44
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Pancreatic Cancers
Kristy Perez · CivaTech Oncology (United States) · funded by National Institutes of Health
2016–2017 · research · R44
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Pancreatic Cancers
Kristy Perez · CivaTech Oncology (United States) · funded by National Institutes of Health
2016–2026 · research · R44
Commercializing CivaSheet for Pancreatic Cancer Patients
Kristy Perez · CivaTech Oncology (United States) · funded by National Institutes of Health
2016–2026 · research · R44
Commercializing CivaSheet for Pancreatic Cancer Patients
Kristy Perez · CivaTech Oncology (United States) · funded by National Institutes of Health
2016–2026 · research · R44
Commercializing CivaSheet for Pancreatic Cancer Patients
Kristy Perez · CivaTech Oncology (United States) · funded by National Institutes of Health
